Phlomis lanceolata
Phlomis lanceolata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Phlomis lanceolata is a botanical species recognized for its diverse chemical profile and potential therapeutic activities. Research into its leaves and flowers has identified key bioactive compounds, including Forsythoside B, Phlinoside C, and Verbascoside. These constituents are often studied through various preparations, such as methanolic total extracts and specific methanol extracts of the leaves. Furthermore, advanced analysis involves utilizing partition fractions of chloroform and ethyl acetate to isolate specific components. Ultimately, these studies focus on evaluating the plant's significant antibacterial properties for medicinal applications.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Southern America
- Plant Parts
- Flower · Leaf
Classification
Taxonomy
Phlomis lanceolata is a distinctive member of the kingdom Plantae. This species belongs to the genus Phlomis, which highlights its unique morphological characteristics. Within its broader classification, it is nested under the order Lamiales. It further belongs to the family Lamiaceae, a group known for its diverse botanical traits. Ultimately, its biological lineage is defined by its placement within the class Equisetopsida.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Phlomis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Phlomis lanceolata is a resilient species primarily found within the Asia-Temperate region. Its natural distribution spans several key areas across Western Asia, showcasing its adaptability to diverse landscapes. Specifically, this plant can be found flourishing in the rugged terrains of Iran. It also maintains a significant presence throughout the diverse ecosystems of Iraq. Furthermore, the species is widely distributed across Türkiye, marking its importance to the regional flora.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Phlomis lanceolata is a self-supporting plant that maintains its own structural integrity without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Phlomis lanceolata, an Iranian medicinal plant, has demonstrated significant antibacterial activity against several dangerous pathogens. Recent studies focused on isolating phenylethanoid glycosides from the methanol extract of its leaves to evaluate their medicinal potential. Researchers successfully identified three specific compounds, including forsythoside B, phlinoside C, and verbascoside, through advanced chromatographic and spectroscopic techniques. When tested against five multi-drug-resistant strains of Staphylococcus aureus, both forsythoside B and verbascoside exhibited considerable inhibitory effects. These findings highlight the plant's potential role in developing new treatments to combat increasingly resistant bacterial infections.
Compounds
Phlomis lanceolata is an Iranian medicinal plant that has been studied for its rich chemical composition. Research conducted on the methanol extract of its leaves has successfully isolated three specific phenylethanoid glycosides. Specifically, the plant contains forsythoside B, phlinoside C, and verbascoside. These compounds were identified through advanced structural analysis techniques, including mass spectrometry and nuclear magnetic resonance. Understanding these internal relationships is crucial for evaluating the plant's potential antibacterial properties against drug-resistant bacteria.
Conditions
Phlomis lanceolata contains specific phenylethanoid glycosides that demonstrate significant antibacterial activity against multiple-drug-resistant strains of Staphylococcus aureus. Researchers isolated three key compounds, forsythoside B, phlinoside C, and verbascoside, from the methanol extract of the plant's leaves. Testing against five different multi-drug-resistant strains revealed that forsythoside B and verbascoside possess considerable inhibitory properties. In contrast, the compound phlinoside C remained inactive at the concentrations used during the serial dilution assays. These findings highlight the potential of certain constituents within Phlomis lanceolata to combat resistant bacterial infections.
Preparations
Phlomis lanceolata is prepared as a metanolic total extract to evaluate its cytotoxic activity against various cancer cell lines. The plant is also prepared as a methanol extract of the leaves for the isolation of phenylethanoid glycosides. To further investigate specific biological effects, Phlomis lanceolata is prepared as partition fractions of chloroform. Additionally, the plant is prepared as partition fractions of ethyl acetate for phytochemical analysis. Finally, Phlomis lanceolata is prepared as partition fractions of petroleum ether, which has shown high cytotoxic activity against multiple cell lines.
Parts used
Phlomis lanceolata is a versatile medicinal plant that offers significant therapeutic potential through its various botanical components. Research indicates that the flowering aerial parts of the plant contain fractions capable of exhibiting high cytotoxic activity against several cancer cell lines. Additionally, the leaves of this species serve as a rich source of phenylethanoid glycosides, such as forsythoside B and verbascoside. These specific compounds isolated from the foliage have demonstrated considerable antibacterial properties against multi-drug-resistant strains of Staphylococcus aureus. Ultimately, both the flowers and leaves of Phlomis lanceolata play crucial roles in providing the phytochemicals necessary for modern medicinal discovery.